Surgical Science Sweden AB (SUSRF)
Surgical Science Sweden AB operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Gothenburg, VG, SE. The stock last traded at $5.20, up 0.00% on the session, giving a market capitalisation of $265.3M. On trailing twelve-month figures it carries a trailing P/E of 26.97, a net margin of 9.1%. Its beta of 0.61 implies it has historically moved less than the broad market.
Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, for procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.
Surgical Science Sweden AB is most often compared with the following Healthcare names: